Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
24.19
0.26 (1.09%)
At close: May 02, 2025, 3:59 PM
24.18
-0.04%
After-hours: May 02, 2025, 05:57 PM EDT
1.09% (1D)
Bid | 24.18 |
Market Cap | 137.19B |
Revenue (ttm) | 63.63B |
Net Income (ttm) | 8.01B |
EPS (ttm) | 1.38 |
PE Ratio (ttm) | 17.53 |
Forward PE | 8.03 |
Analyst | Hold |
Ask | 24.19 |
Volume | 28,681,997 |
Avg. Volume (20D) | 52,634,438 |
Open | 24.27 |
Previous Close | 23.93 |
Day's Range | 23.97 - 24.30 |
52-Week Range | 20.92 - 31.54 |
Beta | 0.60 |
About PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable an...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jun 1, 1972
Employees 81,000
Stock Exchange NYSE
Ticker Symbol PFE
Website https://www.pfizer.com
Analyst Forecast
According to 13 analyst ratings, the average rating for PFE stock is "Hold." The 12-month stock price forecast is $29.5, which is an increase of 21.95% from the latest price.
Stock ForecastsEarnings Surprise
Pfizer has released their quartely earnings
on Apr 29, 2025:
3 days ago
+3.21%
Pfizer shares are trading higher following a Q1 EP...
Unlock content with
Pro Subscription
1 month ago
-1.33%
Pfizer shares are trading lower following a Wall Street Journal report suggesting US prosecutors are probing a tip about the timing of the company's COVID-19 vaccine, which allegedly came via GSK.